HomeDEEPAKNTR › Filing
🔔 Get instant alerts when DEEPAKNTR files quarterly results on BSE Start free trial →

Q1 - FY 2027 Investor Presentation

Filed: 04 Aug 2026, 22:42 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q1 FY27 revenue 2,592 Cr +35% y-y, EBITDA 554 Cr +159% y-y, PAT 345 Cr +207% y-y - Advanced Intermediates revenue 1,775 Cr +36% y-y; EBIT 418 Cr +254% y-y - Strong outlook with new product launches, debottlenecking, and specialty plants commissioning - Polycarbonate project commissioning targeted in 2028 with 2,900 Cr total commitment - Focus on supply chain resilience, backward integration, and renewable energy transition - CMD: "Long-term strategy translating into stronger structural advantages and sustainable growth" - Renewable energy investments saved ~4.5 Cr in Q1 FY27, with plans to increase savings
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 DEEPAKNTR — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add DEEPAKNTR to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Deepak Nitrite Limited

Important. The summary above is generated automatically from Deepak Nitrite Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.